Tudor Investment Corp
DERM icon

Tudor Investment Corp’s Journey Medical DERM Stock Holding History

Tudor Investment Corp’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,602
Closed -$57K – 2148
2021
Q4 		$57K Buy
+10,602
New +$76.8K ﹤0.01% 2263

Other funds holding DERM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tudor Investment Corp's DERM Position: Q1 2022 in Review

Tudor Investment Corp sold out of Journey Medical (DERM) in Q1 2022, closing a stake of 10,602 shares — an estimated $57K sold.

Tudor Investment Corp first reported a position in DERM in Q4 2021 and held it in 1 quarter. The position peaked at $57K in Q4 2021. 14 funds tracked by Wall St. Rank hold DERM as of Q1 2022.

  • Tudor Investment Corp reported no remaining Journey Medical position as of Q1 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 10,602 Journey Medical shares in Q1 2022, an estimated $57K.
  • Tudor Investment Corp first reported a position in Journey Medical in Q4 2021 and held it in 1 quarter.
  • Tudor Investment Corp's Journey Medical position peaked at $57K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Journey Medical as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.